Bespoke Extracts (BSPK) Net Cash Flow (2011 - 2025)
Bespoke Extracts (BSPK) reported Net Cash Flow of $15380.0 for Q3 2025, up 559.65% on a YoY basis from $2331.5 in Q3 2024, and up 153.03% sequentially from -$29002.0 in Q2 2025.
Bespoke Extracts (BSPK) Net Cash Flow (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Net Cash Flow data on file, last reported at $15380.0 in Q3 2025.
- For the quarter ending Q3 2025, Net Cash Flow rose 559.65% year-over-year to $15380.0; the trailing twelve-month figure through Sep 2025 stood at -$4702.0 (down 121.93% YoY), and the FY2024 full-year result was $53698.0, up 401.23% from the prior year.
- Net Cash Flow advanced to $15380.0 in Q3 2025, from -$29002.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $380716.0 in Q2 2022 to a low of -$464191.0 in Q3 2022.
- A 5-year average of -$21676.7 and a median of -$2418.0 in 2023 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 762.84% in 2021, while the deepest fall reached 832.8% in 2021.
- Tracing BSPK's Net Cash Flow over 5 years: stood at -$4882.0 in 2021, then soared by 378.08% to $13576.0 in 2022, then sank by 51.33% to $6607.0 in 2023, then jumped by 488.16% to $38860.0 in 2024, then tumbled by 60.42% to $15380.0 in 2025.
- Business Quant data shows BSPK's Net Cash Flow at $15380.0 in Q3 2025, -$29002.0 in Q2 2025, and -$29940.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 15,380.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 15,380.00 |
| Sep 30, 2025 | 15,380.00 |
| Jun 30, 2025 | -29,002.00 |
| Jun 30, 2025 | -29,002.00 |
| Mar 31, 2025 | -29,940.00 |
| Mar 31, 2025 | -29,940.00 |
| Dec 31, 2024 | 38,860.00 |
| Dec 31, 2024 | 38,860.00 |
| Sep 30, 2024 | -3,346.00 |
| Sep 30, 2024 | -3,346.00 |
| Jun 30, 2024 | 10,375.00 |
| Jun 30, 2024 | 10,375.00 |
| Mar 31, 2024 | 7,809.00 |
| Mar 31, 2024 | 7,809.00 |
| Dec 31, 2023 | 6,607.00 |
| Dec 31, 2023 | 6,607.00 |
| Sep 30, 2023 | -1,947.00 |
| Sep 30, 2023 | -1,947.00 |
| Jun 30, 2023 | -2,418.00 |
| Jun 30, 2023 | -2,418.00 |